Kk Shah Hospitals Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of KK Shah Hospitals Ltd is ₹ 45 as of 21 Oct 15:30 . The P/E Ratio of KK Shah Hospitals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of KK Shah Hospitals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 13.96 crore on March 2025 . This represents a CAGR of -32.93% over 5 years The Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 7 years .

About KK Shah Hospitals Ltd

KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
The Company is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of KK Shah Hospitals Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, KK Shah Hospitals Ltd or Vanta Bioscience Ltd?

Market cap of KK Shah Hospitals Ltd is 30 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of KK Shah Hospitals Ltd and Vanta Bioscience Ltd?

The stock performance of KK Shah Hospitals Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KK Shah Hospitals Ltd and Vanta Bioscience Ltd?

As of October 24, 2026, the KK Shah Hospitals Ltd stock price is INR ₹45.0. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of KK Shah Hospitals Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of KK Shah Hospitals Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.